The next natural drug candidate, fumitremorgin C at micromolar concentrations inhibited expression of the breast cancer resistant protein (BCRP/ABCG2) that mediates transport of chemotherapeutic agents [65]. The gene discussed is ABCG2; the disease is cancer.